Form D · Biotechnology

Kit Company, Inc.

San Francisco, CA · CIK 0001818899

Offering snapshot reported Jan 27, 2021 · SEC filing

Reported sold
$3.32M
Offering amount: $3.32M
Investors reported
17
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 16, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.66M$3.32MNov 27, 2020: $2,480,000.00Nov 27, 2020Jan 27, 2021: $3,323,000.00Jan 27, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,480,000 → $3,323,000
  • Reported investors14 → 17

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 27, 2021Amendment$3,323,000$843,000vs Nov 27, 202017SEC filing
Nov 27, 2020Initial$2,480,000No comparison14SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-381599

Source: Form D, filed Jan 27, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Philip Fung Director, Executive
Roberto Sanabria Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
953 Indiana Street
San Francisco, CA, 94107